ArticlePloS one2026
Revisiting the relation between oral contraceptive use and attentional engagement in everyday life: The role of formulation.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral contraceptives (OCs) are composed of artificial estrogen (ethinyl-estradiol) and/or progesterone (progestin), which can attach to receptors in the brain and potentially influence cognition. One prior study suggested that OC use was associated with increased mind-wandering - implying that OC use was associated with detriments to attention. In contrast, two subsequent well-powered conceptual replications of this initial finding revealed little evidence that OC use was related to increases in inattentiveness (including mind-wandering). However, these later studies collapsed across different OC formulations, which may obscure effects specific to particular formulations. In the present study, we investigated the possibility that OC formulation might differentially relate to attention-related traits. To do this, we collected trait-level reports of the tendency to experience attention related errors, attention lapses, spontaneous and deliberate mind-wandering, boredom, and flow in undergraduate females using OCs, and we collected the brand of OC used from which it was possible to derive the formulation. OC formulations differed in ethinyl-estradiol dose, progestin dose, dosing schedule, hormonal activity (or potency), and the type (or 'generation') of progestin used. We found no evidence that different OC formulations were related to differences in attention-related traits, which suggests that OC users can be treated as a homogenous group when examining trait-level attention. Comparisons of OC users (collapsing across formulation) to non-users again revealed no significant differences in trait-level attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.